The crisis facing rare disease and disability families in Connecticut is caused by systemic underinvestment, administrative barriers, and policy choices.

Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...

Collaboration will advance a next generation gene editing approach by combining Seamless’ expertise in developing highly precise and efficient ...

Drug Farm, a clinical-stage biopharmaceutical company advancing two novel small molecule drugs for ROSAH syndrome and hepatitis B, today announced that the U.S. Food and Drug Administration (FDA) has ...

Every second, millions of cells in your body divide in two. In the space of an hour, they duplicate their DNA and grow a web of protein fibers around it called a spindle.

Given her event-free years or over a decade of high LDL levels, the team arranged to monitor her coronary anatomy every 2 ...

Regenxbio Inc. faces pivotal catalysts in 2026, notably RGX-121's FDA decision and RGX-202 Duchenne data, potentially ...

Jim Ambrose spent his childhood in Baton Rouge, Louisiana, living as a girl named Kristi. He enjoyed a supportive family and ...

Imagine seeing multiple doctors for multiple symptoms — from joint instability, debilitating fatigue and chronic pain to ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects healthy upside for Novo Nordisk stock through ...

Baylor College of Medicine’s board of trustees named Dr. Jakub Tolar the next president, CEO and executive dean of the medical school, administrators announced Thursday.

A new study has unveiled when chronic myeloid leukemia, a type of cancer that affects the blood and bone marrow, arises in life and how fast it grows. Researchers reveal explosive growth rates of ...